ATPW
VNRX icon

Ashton Thomas Private Wealth’s VolitionRx Ltd VNRX Stock Holding History

Ashton Thomas Private Wealth’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-356
Closed -$4.31K – 1806
2024
Q2 		$4.31K Buy
+356
New +$5.21K ﹤0.01% 1600

Other funds holding VNRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ashton Thomas Private Wealth's VNRX Position: Q3 2024 in Review

Ashton Thomas Private Wealth sold out of VolitionRx Ltd (VNRX) in Q3 2024, closing a stake of 356 shares — an estimated $4.31K sold.

Ashton Thomas Private Wealth first reported a position in VNRX in Q2 2024 and held it in 1 quarter. The position peaked at $4.31K in Q2 2024. 22 funds tracked by Wall St. Rank hold VNRX as of Q3 2024.

  • Ashton Thomas Private Wealth reported no remaining VolitionRx Ltd position as of Q3 2024 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 356 VolitionRx Ltd shares in Q3 2024, an estimated $4.31K.
  • Ashton Thomas Private Wealth first reported a position in VolitionRx Ltd in Q2 2024 and held it in 1 quarter.
  • Ashton Thomas Private Wealth's VolitionRx Ltd position peaked at $4.31K in Q2 2024.
  • 22 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2024.

Based on Ashton Thomas Private Wealth's 13F filing for Q3 2024, filed 5 Nov 2024.